Therese Törngren

2.1k total citations
26 papers, 1.1k citations indexed

About

Therese Törngren is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Therese Törngren has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Therese Törngren's work include BRCA gene mutations in cancer (11 papers), Cancer Genomics and Diagnostics (11 papers) and Genomic variations and chromosomal abnormalities (5 papers). Therese Törngren is often cited by papers focused on BRCA gene mutations in cancer (11 papers), Cancer Genomics and Diagnostics (11 papers) and Genomic variations and chromosomal abnormalities (5 papers). Therese Törngren collaborates with scholars based in Sweden, Denmark and United States. Therese Törngren's co-authors include Anders Kvist, Martin Lauss, Katja Harbst, Åke Borg, Johan Vallon‐Christersson, Göran Jönsson, Frida Rosengren, Markus Ringnér, Rikke Andersen and Inge Marie Svane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Therese Törngren

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Therese Törngren Sweden 15 605 555 313 295 263 26 1.1k
Christina I. Herold United States 11 770 1.3× 388 0.7× 461 1.5× 325 1.1× 117 0.4× 26 1.3k
Alexander Davis United States 8 376 0.6× 795 1.4× 746 2.4× 160 0.5× 150 0.6× 10 1.2k
Collin Tokheim United States 16 343 0.6× 912 1.6× 494 1.6× 179 0.6× 136 0.5× 20 1.3k
Jennifer D. Thompson United States 8 392 0.6× 405 0.7× 308 1.0× 543 1.8× 231 0.9× 11 1.2k
Oday Hamid United States 15 685 1.1× 669 1.2× 123 0.4× 111 0.4× 175 0.7× 41 1.2k
Francesco Favero Denmark 8 668 1.1× 679 1.2× 725 2.3× 178 0.6× 117 0.4× 10 1.4k
Inga Hansine Rye Norway 9 330 0.5× 628 1.1× 606 1.9× 226 0.8× 60 0.2× 13 1.1k
David Gancberg Belgium 14 1.1k 1.8× 631 1.1× 374 1.2× 153 0.5× 94 0.4× 32 1.5k
Jolanta Kupryjańczyk Poland 23 485 0.8× 839 1.5× 472 1.5× 278 0.9× 118 0.4× 70 1.7k
Arthur Kwok Leung Cheung Hong Kong 18 337 0.6× 698 1.3× 362 1.2× 81 0.3× 117 0.4× 27 1.1k

Countries citing papers authored by Therese Törngren

Since Specialization
Citations

This map shows the geographic impact of Therese Törngren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Therese Törngren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therese Törngren more than expected).

Fields of papers citing papers by Therese Törngren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Therese Törngren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Therese Törngren. The network helps show where Therese Törngren may publish in the future.

Co-authorship network of co-authors of Therese Törngren

This figure shows the co-authorship network connecting the top 25 collaborators of Therese Törngren. A scholar is included among the top collaborators of Therese Törngren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Therese Törngren. Therese Törngren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kvist, Anders, Anders Kämpe, Therese Törngren, et al.. (2025). Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer. Breast Cancer Research. 27(1). 160–160.
2.
Öfverholm, Anna, Therese Törngren, Anna Rosén, et al.. (2023). Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. 23(1). 738–738. 5 indexed citations
3.
Törngren, Therese, Anders Kvist, Georgia Kokaraki, et al.. (2021). Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers. 13(20). 5240–5240. 3 indexed citations
4.
Lauss, Martin, Marco Donia, Katja Harbst, et al.. (2020). Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature Communications. 11(1). 1714–1714. 5 indexed citations
5.
Nilsson, Martin, Therese Törngren, Karin Henriksson, et al.. (2017). BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer. Breast Cancer Research and Treatment. 168(1). 117–126. 14 indexed citations
6.
Lauss, Martin, Marco Donia, Katja Harbst, et al.. (2017). Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature Communications. 8(1). 1738–1738. 317 indexed citations
7.
Pelttari, Liisa M., Hussein Shimelis, Anders Kvist, et al.. (2017). Gene‐panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication. Clinical Genetics. 93(3). 595–602. 9 indexed citations
8.
Harbst, Katja, Martin Lauss, Helena Cirenajwis, et al.. (2016). Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma. Cancer Research. 76(16). 4765–4774. 77 indexed citations
9.
Rak, Justyna, Katie Foster, Therese Törngren, et al.. (2016). Cytohesin 1 regulates homing and engraftment of human hematopoietic stem and progenitor cells. Blood. 129(8). 950–958. 19 indexed citations
10.
Galeev, Roman, Praveen Kumar, Björn Nilsson, et al.. (2016). Genome-wide RNAi Screen Identifies Cohesin Genes as Modifiers of Renewal and Differentiation in Human HSCs. Cell Reports. 14(12). 2988–3000. 61 indexed citations
11.
Winter, Christof, Martin Nilsson, Eric Olsson, et al.. (2016). Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic. Annals of Oncology. 27(8). 1532–1538. 105 indexed citations
12.
Rohlin, Anna, Eva Rambech, Anders Kvist, et al.. (2016). Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Familial Cancer. 16(2). 195–203. 45 indexed citations
13.
Olsson, Eleonor, Christof Winter, Anthony M. George, et al.. (2015). Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer. PLoS ONE. 10(12). e0144528–e0144528. 5 indexed citations
14.
Harbst, Katja, Johan Staaf, Martin Lauss, et al.. (2012). Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma. Clinical Cancer Research. 18(15). 4026–4036. 72 indexed citations
15.
Törngren, Therese, et al.. (2010). IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer. Familial Cancer. 10(2). 173–185. 14 indexed citations
16.
Törngren, Therese, et al.. (2010). Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families. Molecular Genetics and Metabolism. 102(1). 82–90. 4 indexed citations
17.
Borg, Åke, Robert W. Haile, Kathleen E. Malone, et al.. (2010). Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Human Mutation. 31(3). E1200–E1240. 103 indexed citations
18.
Reding, Kerryn W., Jonine L. Bernstein, Bryan Langholz, et al.. (2010). Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Research and Treatment. 123(2). 491–498. 43 indexed citations
19.
Figueiredo, Jane C., Robert W. Haile, Leslie Bernstein, et al.. (2009). Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study. Breast Cancer Research and Treatment. 120(1). 175–183. 19 indexed citations
20.
Staaf, Johan, Therese Törngren, Eva Rambech, et al.. (2008). Detection and precise mapping of germline rearrangements inBRCA1, BRCA2, MSH2, andMLH1using zoom-in array comparative genomic hybridization (aCGH). Human Mutation. 29(4). 555–564. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026